Tonix Pharmaceuticals says Dr. Reddy's files ANDA with Paragraph IV certification for generic Tonmya
TNXP•Dr. Reddy's filed an ANDA on Oct. 1 with a Paragraph IV certification challenging four Tonmya patents listed in the FDA Orange Book; Tonix said it intends to enforce its intellectual property rights.
1. Patent challenge
Tonix Pharmaceuticals said Dr. Reddy's filed an ANDA on Oct. 1 with a Paragraph IV patent certification for generic Tonmya. The certification challenges four Tonmya patents listed in the FDA Orange Book, and Tonix said it intends to enforce its intellectual property rights.
